A Cleveland Clinic trial studies a 12-week web-based coaching program for those with psoriatic disease.
Read MoreUpdate: Zika and Rheumatology
A brief update on Zika for practicing rheumatologists in North America.
Connecting the Dots: Clinic for Adult Autoinflammatory Diseases
As advances in genomic medicine improve the diagnosis of autoinflammatory disease and help us recognize new disorders in this class, the need for coordinated care intensifies.
PRECISION Results = Precisely Tailored Arthritis Treatment
Subgroup analyses from the PRECISION trial allow rheumatologists to offer individualized treatment to OA and RA patients on chronic NSAIDs.
Vaccines in Immunosuppressed Patients
Rheumatologists eagerly await the day when we do not have to juggle protection against herpes zoster with the risks of giving a live vaccine to patients on high-dose prednisone and/or biologic DMARDs.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Immune-Related Adverse Events
New therapies that harness the immune system to treat cancer are causing autoimmune inflammatory conditions in patients.
Race Against Vision Loss in Inflammatory Eye Disease
Uveitis accounts for 10-15 percent of legal blindness in the United States. At Cleveland Clinic, multicenter collaboration, fast-track evaluation and treatment help patients avoid vision loss.
Azathioprine as a Steroid-Sparing Agent for Idiopathic Recurrent Pericarditis
Many patients with idiopathic recurrent pericarditis require prolonged glucocorticoids (GC), but GCs increase morbidity. Cleveland Clinic is studying alternative agents, including azathioprine, for these patients.
Improving Post-transplant Quality of Life: Fewer Fractures for Recipients
Cleveland Clinic’s osteoporosis and transplant centers have teamed up to implement a systematic approach to managing bone health in all transplant candidates, significantly decreasing the incidence of osteoporosis and improving quality of life.
Preventing Acute Bleeding Episodes in Gastric Antral Vascular Ectasia
Results of a small retrospective study on the use of immunosuppressive therapy show promise for preventing recurrent bleeding episodes in GAVE.
Asymmetric Dimethylarginine as a Novel Biomarker for Cardiovascular Risk in Psoriatic Diseases
Our laboratory tests whether aberrant levels of plasma and tissue L-arginine metabolites serve as an early, non-invasive predictor of CV disease in psoriatic patients.